PIM
GILD icon

Plato Investment Management’s Gilead Sciences GILD Stock Holding History

Plato Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.35M Sell
50,583
-698
-1% -$92K 0.36% 53
2026
Q1 		$7.15M Buy
51,281
+2,426
+5% +$340K 0.48% 42
2025
Q4 		$6.03M Sell
48,855
-2,227
-4% -$271K 0.39% 54
2025
Q3 		$5.63M Buy
51,082
+6,668
+15% +$758K 0.38% 54
2025
Q2 		$4.91M Sell
44,414
-2,068
-4% -$220K 0.37% 60
2025
Q1 		$5.26M Sell
46,482
-15,097
-25% -$1.56M 0.44% 42
2024
Q4 		$5.71M Buy
61,579
+10,758
+21% +$969K 0.42% 48
2024
Q3 		$4.26M Buy
50,821
+2,468
+5% +$188K 0.35% 68
2024
Q2 		$3.32M Buy
48,353
+1,522
+3% +$102K 0.31% 74
2024
Q1 		$3.43M Buy
46,831
+38,662
+473% +$2.97M 0.35% 71
2023
Q4 		$662K Buy
+8,169
New +$636K 0.81% 24

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Plato Investment Management's GILD Position: Q2 2026 in Review

Plato Investment Management reduced its Gilead Sciences (GILD) stake by 1.4% in Q2 2026, selling an estimated $92K and leaving 50,583 shares worth $6.35M. The position accounts for 0.36% of the portfolio, ranked #53.

Plato Investment Management first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $7.15M in Q1 2026. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Plato Investment Management held 50,583 shares of Gilead Sciences worth $6.35M as of Q2 2026.
  • Plato Investment Management sold 698 Gilead Sciences shares in Q2 2026, an estimated $92K.
  • Gilead Sciences made up 0.36% of Plato Investment Management's portfolio in Q2 2026, its #53 holding.
  • Plato Investment Management first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Plato Investment Management's Gilead Sciences position peaked at $7.15M in Q1 2026.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Plato Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.